ArticleCellular oncology (Dordrecht, Netherlands)2023

Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.

Yi-Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.